We established the validity of a quantitative reverse transcription (RT)-PCR assay for the RNA component of human telomerase (hTR), using the TaqMan fluorogenic detection system. Using this assay, we quantified hTR expression in two human pancreatic cancer cell lines, ASPC-1 and MIAPaCa-2. Our results indicated that hTR expression in MIAPaCa-2 was 1.99-fold higher than that in ASPC-1 cells. This TaqMan RT-PCR assay appears to be useful in determining the amount of hTR in clinical specimens.
Telomerase is an enzyme that synthesizes and adds repetitive telomeric sequences of (TTAGGG) n to ends of chromosomes. Telomerase activity has been found in 85% of human cancers, including stomach, breast, bladder, colon, prostate, and liver, and in immortalized cell lines but not in most nondiseased tissues (1) (2) (3) (4) (5) (6) (7) . Therefore, telomerase is considered closely related to attainment of cellular immortality (one of the steps in carcinogenesis) as well as cellular senescence. Because telomerase-associated genes such as those encoding the human telomerase RNA component (hTR), 3 human telomerase reverse transcriptase, and telomerase-associated protein-1 have been cloned, it has become possible to study the expression of these genes (8 -12) .
Comparison of telomerase activities and expression of the associated genes should help clarify the regulation of telomerase activity. However, hTR expression is detected in cancer as well as in nondiseased tissues, and development of quantitative assays for hTR is required (8, (13) (14) (15) . In addition, telomerase activity and expression of the associated genes have been defined only as positive or negative and not quantified to relate telomerase activity and gene expression. Recently, TaqMan fluorescent chemical analysis has been applied to PCR (16 -18) . This method is based on use of the 5Ј nuclease activity of Taq polymerase to cleave a nonextendable dual-labeled fluorogenic hybridization probe during the extension phase of PCR. TaqMan analysis makes quantitative PCR or reverse transcription (RT)-PCR (19, 20) attainable. Thus, we established a quantitative assay for hTR expression in two human pancreatic cancer cell lines, ASPC-1 and MIAPaCa-2, using TaqMan RT-PCR.
Materials and Methods cells
Human pancreatic cancer cell lines were obtained from the American Type Culture Collection. ASPC-1 cells were cultured in RPMI-1640 (Nipro) supplemented with 200 mL/L heat-inactivated fetal calf serum (Biological Industries), and MIAPaCa-2 cells were cultured in Dulbecco's modified Eagle's medium (Nipro) supplemented with 100 mL/L heat-inactivated fetal calf serum. and primers was performed by Perkin-Elmer Japan and by Tanaka. Primers and the TaqMan probe for glyceraldehyde-3-phosphate dehydrogenase (GAPDH; TaqMan GAPDH control reagent kit) also were purchased from Perkin-Elmer Applied Biosystems. Table 1 shows the sequences for the TaqMan probes and primers used.
AmpliTaq DNA polymerase extended the primer and displaced the TaqMan probe through its 5Ј-3Ј exonuclease activity. The probes were labeled with a reporter fluorescent dye [6-carboxy-fluorescein (FAM) or 2,7-dimethoxy-4,5-dichloro-6-carboxy-fluorescein (JOE)] at the 5Ј end and a quencher fluorescent dye (6-carboxy-tetramethylrhodamine) at the 3Ј end. Nuclease degradation of the hybridization probe removed the quenching effect of 6-carboxy-tetramethyl-rhodamine from the FAM or JOE fluorescent emission, increasing the peak fluorescent emission at 517 and 554 nm, respectively. No signal was emitted when the probe was intact. Results amplification plots and cycle threshold hTR and GAPDH amplification plots for four different dilutions (containing 100, 50, 10, or 5 ng) of total RNA from ASPC-1 and samples of unknown total RNA concentration from ASPC-1 and MIAPaCa-2 are shown in Fig. 1 . ASPC-1 samples were used as the basis for comparing results and calibration curves. Amplification plots were used to determine the threshold cycle (C T ). To determine the C T values and obtain the linearity of the calibration curves, the optimal ⌬Rn was selected in the exponential phase of amplification plots for each dilution of total RNA. The C T value represented the PCR cycle at which an increase in reporter fluorescence above the line of the optimal ⌬Rn was first detected. Experientially, this line was drawn at a ⌬Rn of 0.05 (usually 10 SD of the baseline) (20) .
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calibration curves
For relative quantification of hTR expression, a calibration curve was constructed. RNA for GAPDH, a "housekeeping" enzyme, was used as an endogenous control. Fig. 2 shows calibration curves for hTR and GAPDH RNA quantitation in ASPC-1 cells as detected using FAM-and JOE-labeled probes. The calibration curve as an xy (scatter) plot represented the log of the input amount (log ng of total starting RNA) as x and C T as y. Equations were derived from the lines of the calibration curves. The two formulas for log ng of hTR and GAPDH were as follows: hTR, y ϭ Ϫ3.26x ϩ 28.63 (r ϭ 0.999); GAPDH, y ϭ Ϫ3.19x ϩ 26.46 (r ϭ 0.997). When the C T value of a sample was substituted into the formula for hTR or GAPDH, the concentration of hTR or GAPDH could be calculated. Table 2 shows the mean concentrations of hTR and GAPDH found in ASPC-1 and MIAPaCa-2 in triplicate determinations of each sample, together with normalized concentrations of hTR. To normalize for differences in the amount of total RNA added to each reaction, GAPDH was selected as an endogenous RNA control. The normalized concentration of hTR, an arbitrary number that can be used to compare the relative amounts of hTR in different samples, was determined by dividing the concentration of hTR by the concentration of GAPDH. Our results indicated that hTR expression in MIAPaCa-2 was 1.99-fold higher than in ASPC-1 cells.
data analysis
Discussion
We developed a quantitative RT-PCR assay of hTR, using a TaqMan fluorogenic detection system. In previous reports, hTR was examined using RT-PCR or Northern blots. (8, 9, (13) (14) (15) To make the RT-PCR more quantitative using the conventional internal standard method, it was necessary to determine the optimal cycle number and sample concentration to compare the amounts of amplification products in the exponential amplification phase of PCR. This implies that the PCR assay should be performed in serial cycles on serially diluted samples. A large amount of mRNA and a lengthy series of steps (mRNA preparation, electrophoresis, blotting, hybridization, and autoradiography) are needed to perform Northern analysis, requiring Ͼ1 day. In the present assay using the TaqMan fluorogenic detection system, the amplification signals are detected in real time, permitting accurate quantification of amounts of initial RNA template accurately because the system can select signals easily in the exponential amplification phase of PCR. In addition, hTR Four different dilutions, including 100 ng (red), 50 ng (blue), 10 ng (green), or 5 ng (pink) of total RNA from ASPC-1, and unknown sample concentrations (yellow and purple) were tested in triplicate. The unknown samples were obtained from the total RNA extract of MIAPaCa-2 and ASPC-1 cells. Amplification plots were used to determine the C T ; the xy plots represent the PCR cycle number as x and the mean ⌬Rn value as y. To determine the optimal C T , the optimal ⌬Rn (y ϭ 0.05) was selected in the exponential phase of amplification plots for each dilution of total RNA (See Results for details).
can be analyzed in a single tube, from RT-PCR to detection, in ϳ3 h. Because the TaqMan probe specifically hybridizes with its target, a sequence-specific amplification signal was detected. Our data demonstrated that hTR expression in MIAPaCa-2 cells was 1.99-fold higher than in ASPC-1. Additional studies are needed to determine whether this difference is clinically significant. In addition, we have found in preliminary studies that hTR expression is measurable using TaqMan RT-PCR in clinical gastric mucosal specimens, including those showing gastric cancer, intestinal metaplasia, atrophic gastritis, and nondiseased gastric mucosa (unpublished data). hTR expression was detected in cancer as well as in nondiseased tissues. Therefore, to clarify the relationship between hTR expression and telomerase activity, a quantitative assay for hTR is required. In addition, known quantities of hTR can be used to construct the calibration curve, and thus normalization is not necessary.
In conclusion, the TaqMan RT-PCR assay is a rapid, accurate method for measuring hTR expression and shows promise for the quantification of hTR in clinical specimens.
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